Position in GLUE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,133,100
+$2,893,342 QoQ
Shares Held
129,467
+788.3% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 193 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. GLUE ranks #89 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in GLUE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,133,100 | 129,467 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $239,758 | 14,575 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $167,556 | 10,686 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $13,144 | 1,774 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $103,337 | 22,913 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $144,367 | 31,114 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $311,486 | 44,883 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $159,545 | 30,103 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $35,671 | 9,538 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $41,580 | 5,898 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $24,848 | 4,398 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,386 | 707 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $75,199 | 10,978 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $8,093 | 1,039 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $10,197 | 1,340 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $12,336 | 1,510 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $30,798 | 3,185 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $34,979 | 2,495 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $98,077 | 4,803 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $29,431 | 1,321 | Shares | Defined | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||